Market Cap 50.90M
Revenue (ttm) 0.00
Net Income (ttm) -34.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 2.73
Volume 397,600
Avg Vol 1,029,798
Day's Range N/A - N/A
Shares Out 55.82M
Stochastic %K 3%
Beta 1.57
Analysts Strong Sell
Price Target $7.50

Company Profile

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associate...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 208 3343
Address:
303A College Road East, Princeton, United States
dvice2
dvice2 Jun. 24 at 2:30 PM
$PDSB why isnt company voting on an R/S this summer? most every company who has dropped below a dollar and has faced delisting has this in place..unless it already is approved and i missed it in previous filings 🤷‍♂️
2 · Reply
Ydelaporte
Ydelaporte Jun. 24 at 1:39 PM
$PDSB damn what’s that 100k block doing there…?
0 · Reply
EdwardBush
EdwardBush Jun. 23 at 8:59 PM
$PDSB I lost on this POS around £22k 18 months ago, I'm glad that I sold and moved on, now I got all my money back on OSCR and I will make even more on ZETA... sometimes you just need to let it go
1 · Reply
Mr_Charlie
Mr_Charlie Jun. 23 at 1:33 PM
$PDSB I wonder when are they gonna announce bankruptcy?
0 · Reply
Jayy25
Jayy25 Jun. 23 at 1:19 PM
$PDSB dog water
0 · Reply
wyoming2020
wyoming2020 Jun. 22 at 9:41 PM
$PDSB my opinion only but some patent value with HPV oncoproteins connected to viral / non viral vector. Patent value at this price in my view only
1 · Reply
wyoming2020
wyoming2020 Jun. 22 at 6:17 PM
$PDSB seeds of innovation
0 · Reply
alphabetsop
alphabetsop Jun. 20 at 3:12 PM
$PDSB Frank's 'accelerated' strategy has become a joke. The theoretical time saved on the back end of the trial has already been wasted on the front end by the extended pause. The 9 month delay already is a sunk cost. If a trial is shortened by 12 months due to a faster endpoint, but you spend 9 to 10 months sitting on your hands doing zero recruiting, the net time saved is essentially zero. Frank and team are doing exactly what month after month other than getting paid. There has been zero updates on any trial or indication.
2 · Reply
KG1816
KG1816 Jun. 18 at 7:43 PM
$PDSB A ton of sh*t being talked and I get it, but the way I see it…a couple million shares were exchanged the last 3 days. Doesn’t look like people are fleeing to the door to me personally.
1 · Reply
EddieH2020
EddieH2020 Jun. 18 at 4:22 PM
$PDSB I literally gave you all the blueprint months ago. People at PDSB just want to stay poor and that’s sad. Instead of buying $SLS lol Frank Bedu Addo is going to be convicted for his crimes while Angelos leads SLS longs to a buyout of epic proportions 🚀
0 · Reply
Latest News on PDSB
PDS Biotechnology Proxy statement: Proxy filing

Jun 15, 2026, 8:00 AM EDT - 9 days ago

PDS Biotechnology Proxy statement: Proxy filing


PDS Biotechnology Earnings Call Transcript: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 weeks ago

PDS Biotechnology Earnings Call Transcript: Q1 2026


PDS Biotechnology Earnings release: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 weeks ago

PDS Biotechnology Earnings release: Q1 2026


PDS Biotechnology Quarterly report: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 weeks ago

PDS Biotechnology Quarterly report: Q1 2026


PDS Biotechnology Registration statement: Registration filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

PDS Biotechnology Registration statement: Registration filing


PDS Biotechnology Slides: Corporate presentation

Apr 22, 2026, 7:00 AM EDT - 2 months ago

PDS Biotechnology Slides: Corporate presentation


PDS Biotechnology Earnings Call Transcript: Q4 2025

Mar 30, 2026, 8:00 AM EDT - 3 months ago

PDS Biotechnology Earnings Call Transcript: Q4 2025


PDS Biotechnology Annual report: Q4 2025

Mar 30, 2026, 8:00 AM EDT - 3 months ago

PDS Biotechnology Annual report: Q4 2025


PDS Biotechnology Earnings release: Q4 2025

Mar 30, 2026, 8:00 AM EDT - 3 months ago

PDS Biotechnology Earnings release: Q4 2025


PDS Biotechnology Earnings Call Transcript: Q3 2025

Nov 13, 2025, 8:00 AM EST - 7 months ago

PDS Biotechnology Earnings Call Transcript: Q3 2025


PDS Biotechnology Quarterly report: Q3 2025

Nov 13, 2025, 8:00 AM EST - 7 months ago

PDS Biotechnology Quarterly report: Q3 2025


PDS Biotechnology Earnings release: Q3 2025

Nov 13, 2025, 8:00 AM EST - 7 months ago

PDS Biotechnology Earnings release: Q3 2025


PDS Biotechnology Registration statement: Registration Filing

Aug 29, 2025, 8:00 AM EDT - 10 months ago

PDS Biotechnology Registration statement: Registration Filing


PDS Biotechnology Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 11 months ago

PDS Biotechnology Earnings Call Transcript: Q2 2025


PDS Biotechnology Quarterly report: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 11 months ago

PDS Biotechnology Quarterly report: Q2 2025


PDS Biotechnology Earnings release: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 11 months ago

PDS Biotechnology Earnings release: Q2 2025


PDS Biotechnology Transcript: Status Update

Jun 17, 2025, 12:00 PM EDT - 1 year ago

PDS Biotechnology Transcript: Status Update


PDS Biotechnology Registration statement: Registration Filing

May 27, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Registration statement: Registration Filing


PDS Biotechnology Transcript: Study Update

May 23, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Transcript: Study Update


PDS Biotechnology Press release: Study Update

May 23, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Press release: Study Update


PDS Biotechnology Proxy statement: Proxy Filing

May 22, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Proxy statement: Proxy Filing


PDS Biotechnology Earnings Call Transcript: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Earnings Call Transcript: Q1 2025


PDS Biotechnology Quarterly report: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Quarterly report: Q1 2025


PDS Biotechnology Earnings release: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Earnings release: Q1 2025


PDS Biotechnology Proxy statement: Proxy Filing

May 5, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Proxy statement: Proxy Filing


PDS Biotechnology Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Proxy statement: Proxy Filing


PDS Biotechnology Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Proxy statement: Proxy Filing


PDS Biotechnology Earnings Call Transcript: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Earnings Call Transcript: Q4 2024


PDS Biotechnology Annual report: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Annual report: Q4 2024


PDS Biotechnology Earnings release: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

PDS Biotechnology Earnings release: Q4 2024


PDS Biotech Leadership to Participate in March Conferences

Mar 11, 2025, 8:00 AM EDT - 1 year ago

PDS Biotech Leadership to Participate in March Conferences


PDS Biotechnology Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

PDS Biotechnology Earnings Call Transcript: Q3 2024


PDS Biotechnology Quarterly report: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

PDS Biotechnology Quarterly report: Q3 2024


PDS Biotechnology Earnings release: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

PDS Biotechnology Earnings release: Q3 2024


PDS Biotechnology Quarterly report: Q2 2024

Aug 13, 2024, 9:30 AM EDT - 2 years ago

PDS Biotechnology Quarterly report: Q2 2024


PDS Biotechnology Earnings release: Q2 2024

Aug 13, 2024, 9:30 AM EDT - 2 years ago

PDS Biotechnology Earnings release: Q2 2024


dvice2
dvice2 Jun. 24 at 2:30 PM
$PDSB why isnt company voting on an R/S this summer? most every company who has dropped below a dollar and has faced delisting has this in place..unless it already is approved and i missed it in previous filings 🤷‍♂️
2 · Reply
Ydelaporte
Ydelaporte Jun. 24 at 1:39 PM
$PDSB damn what’s that 100k block doing there…?
0 · Reply
EdwardBush
EdwardBush Jun. 23 at 8:59 PM
$PDSB I lost on this POS around £22k 18 months ago, I'm glad that I sold and moved on, now I got all my money back on OSCR and I will make even more on ZETA... sometimes you just need to let it go
1 · Reply
Mr_Charlie
Mr_Charlie Jun. 23 at 1:33 PM
$PDSB I wonder when are they gonna announce bankruptcy?
0 · Reply
Jayy25
Jayy25 Jun. 23 at 1:19 PM
$PDSB dog water
0 · Reply
wyoming2020
wyoming2020 Jun. 22 at 9:41 PM
$PDSB my opinion only but some patent value with HPV oncoproteins connected to viral / non viral vector. Patent value at this price in my view only
1 · Reply
wyoming2020
wyoming2020 Jun. 22 at 6:17 PM
$PDSB seeds of innovation
0 · Reply
alphabetsop
alphabetsop Jun. 20 at 3:12 PM
$PDSB Frank's 'accelerated' strategy has become a joke. The theoretical time saved on the back end of the trial has already been wasted on the front end by the extended pause. The 9 month delay already is a sunk cost. If a trial is shortened by 12 months due to a faster endpoint, but you spend 9 to 10 months sitting on your hands doing zero recruiting, the net time saved is essentially zero. Frank and team are doing exactly what month after month other than getting paid. There has been zero updates on any trial or indication.
2 · Reply
KG1816
KG1816 Jun. 18 at 7:43 PM
$PDSB A ton of sh*t being talked and I get it, but the way I see it…a couple million shares were exchanged the last 3 days. Doesn’t look like people are fleeing to the door to me personally.
1 · Reply
EddieH2020
EddieH2020 Jun. 18 at 4:22 PM
$PDSB I literally gave you all the blueprint months ago. People at PDSB just want to stay poor and that’s sad. Instead of buying $SLS lol Frank Bedu Addo is going to be convicted for his crimes while Angelos leads SLS longs to a buyout of epic proportions 🚀
0 · Reply
Mr_Charlie
Mr_Charlie Jun. 18 at 9:39 AM
$PDSB I am starting to believe that this company pipeline drug doesn't work and all previous trials data has been falsified. I hope it is not the case but when you are in a promissing phase 3 clinical trial the stock price is not 90 cents.
1 · Reply
alphabetsop
alphabetsop Jun. 17 at 6:34 PM
$PDSB beyond words at this point. Frank has been a generational disaster as CEO.
1 · Reply
Ontherag
Ontherag Jun. 17 at 6:23 PM
$PDSB I have an idea for the annual shareholder meeting!
0 · Reply
alphabetsop
alphabetsop Jun. 17 at 6:20 PM
$PDSB stunned it’s approaching July 4 and we are still sitting in silence and sinking towards lows again. wtf is the 7 person leadership team doing every day.
0 · Reply
Test2025
Test2025 Jun. 17 at 1:45 PM
$PDSB so fucking dead for years
0 · Reply
EddieH2020
EddieH2020 Jun. 17 at 12:09 PM
$PDSB When clowns like @Ontherag want to trash other companies but hype this one, I know they have a clear agenda.
0 · Reply
alphabetsop
alphabetsop Jun. 17 at 1:23 AM
$PDSB We are so overdue to hear something about what’s next with P3 or an advancing one of the other indications. Silence for months is deafening.
1 · Reply
dvice2
dvice2 Jun. 17 at 1:02 AM
$PDSB https://ascopubs.org/doi/pdfdirect/10.1200/EDBK-26-516572
0 · Reply
dvice2
dvice2 Jun. 17 at 12:59 AM
$PDSB https://www.barchart.com/story/news/2504210/hpv-recurrent-metastatic-head-and-neck-cancer-pipeline-shows-strong-momentum-as-5-pharma-companies-in-the-race-delveinsight
1 · Reply
Ontherag
Ontherag Jun. 17 at 12:15 AM
$PDSB Love this company. Zero communication and low share count combined with blockbuster drug.
0 · Reply
Mr_Charlie
Mr_Charlie Jun. 16 at 7:51 PM
$PDSB this will be at 30 cents in a few weeks.
0 · Reply
JohntyCT
JohntyCT Jun. 16 at 4:22 PM
$PDSB I’m out (again). Maybe back if we see some announced progress on P3. GTLA.
0 · Reply